BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kim SB, Song IH, Kim YM, Noh R, Kang HY, Lee HI, Yang HY, Kim AN, Chae HB, Lee SH, Kim HS, Lee TH, Kang YW, Lee ES, Kim SH, Lee BS, Lee HY. Long-term treatment outcomes of clevudine in antiviral-naive patients with chronic hepatitis B. World J Gastroenterol 2012; 18(47): 6943-6950 [PMID: 23322992 DOI: 10.3748/wjg.v18.i47.6943]
URL: https://www.wjgnet.com/1948-5182/full/v18/i47/6943.htm
Number Citing Articles
1
Daniel N Clark, Jianming Hu. Unveiling the roles of HBV polymerase for new antiviral strategiesFuture Virology 2015; 10(3): 283 doi: 10.2217/fvl.14.113
2
Altaf Dawood, Syed Abdul Basit, Mahendran Jayaraj, Robert G. Gish. Drugs in Development for Hepatitis BDrugs 2017; 77(12): 1263 doi: 10.1007/s40265-017-0769-2
3
Won Young Tak, Jin Mo Yang, Byung Ik Kim, Soon Koo Baik, Gab Jin Cheon, Kwan Soo Byun, Do Young Kim, Byung Chul Yoo. A randomized, open-label study comparing low-dose clevudine plus adefovir combination therapy with clevudine monotherapy in naïve chronic hepatitis B patientsHepatology International 2014; 8(3): 375 doi: 10.1007/s12072-014-9537-5
4
Daniel N. Clark, Jianming Hu. Hepatitis B virus reverse transcriptase – Target of current antiviral therapy and future drug developmentAntiviral Research 2015; 123: 132 doi: 10.1016/j.antiviral.2015.09.011